Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1974 Oct;6(4):426-31.
doi: 10.1128/AAC.6.4.426.

Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease

Comparative Study

Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease

K R Ratzan et al. Antimicrob Agents Chemother. 1974 Oct.

Abstract

The biliary tract excretion of three cephalosporins, cefazolin, cephaloridine, and cephalothin, was compared in patients with biliary tract disease. In the absence of obstruction, mean antibiotic levels in bile from gall bladder and common duct in patients undergoing cholecystectomy were highest for cefazolin (17 and 31 mug/ml, respectively) than either cephaloridine (7 and 9 mug/ml) or cephalothin (1 and 4 mug/ml). Biliary tract levels generally paralleled serum levels. In no patient with cystic duct obstruction were any of the cephalosporins detectable in appreciable amounts in gall bladder bile. In patients with T-tube drainage given each of the three different cephalosporins on separate days, concentrations of cefazolin in bile were many-fold higher than either cephaloridine or cephalothin. Peak levels of cefazolin in T-tube bile averaged 51 mug/ml after intravenous and 26 mug/ml after intramuscular administration, whereas mean peak levels of cephalothin and cephaloridine were only 6 and 16 mug/ml, respectively. Here, too, T-tube levels reflected serum concentrations and obstruction to biliary flow impaired excretion of each of the drugs.

PubMed Disclaimer

References

    1. Ann Surg. 1967 Oct;166(4):563-72 - PubMed
    1. Gut. 1968 Oct;9(5):536-45 - PubMed
    1. Br Med J. 1969 Jul 12;3(5662):88-9 - PubMed
    1. J Infect Dis. 1971 Dec;124 Suppl:S106-8 - PubMed
    1. J Infect Dis. 1973 Mar;127(3):299-302 - PubMed

Publication types

MeSH terms

LinkOut - more resources